North America Critical Care Equipment Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2024 –2030 |
 Taille du marché (année de référence) |
|
 Taille du marché (année de prévision) |
|
 TCAC |
% |
| Principaux acteurs du marché |
>Marché nord-américain des équipements de soins intensifs, par type de produit (dispositifs thérapeutiques, dispositifs de surveillance des patients, dispositifs de diagnostic, unités et systèmes de soins intensifs et autres dispositifs), population de patients (néonatals, pédiatriques, adultes et gériatriques), utilisateur final (hôpitaux, cliniques spécialisées, centres de chirurgie ambulatoire et autres), canal de distribution (appels d'offres directs, ventes au détail, distribution à des tiers et autres) Tendances et prévisions de l'industrie jusqu'en 2030.
Analyse et perspectives du marché des équipements de soins intensifs en Amérique du Nord
Les patients admis dans une unité de soins intensifs peuvent y être pour diverses raisons, mais ils ont tous en commun le fait qu’ils nécessitent une attention et une surveillance étroites, ainsi qu’un équipement de pointe, souvent une assistance respiratoire et vitale.
Le marché nord-américain des équipements de soins intensifs connaît une croissance considérable en raison de l'augmentation des maladies chroniques telles que le diabète, les troubles cardiovasculaires et les troubles rénaux, entre autres, ce qui entraîne une augmentation du nombre de patients en soins intensifs. Cependant, des réglementations strictes et des politiques de remboursement médiocres pourraient restreindre le marché au cours de la période de prévision. De plus, le coût élevé des équipements de soins intensifs est l'un des facteurs les plus importants qui pourraient entraver la croissance du marché à long terme.
Le développement technologique constitue une opportunité pour les principaux acteurs au cours de la période de prévision. D'un autre côté, le manque de personnel et de formation adéquats constitue un obstacle à la croissance du marché.
Data Bridge Market Research analyse que le marché nord-américain des équipements de soins intensifs devrait atteindre la valeur de 32 864,78 millions USD d'ici 2030, à un TCAC de 8,8 % au cours de la période de prévision. Le type de produit représente le segment de type le plus important du marché en raison de la demande rapide d'équipements de soins intensifs en Amérique du Nord. Ce rapport de marché couvre également en profondeur l'analyse des prix, l'analyse des brevets et les avancées technologiques.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Années historiques |
2021 (personnalisable pour 2020-2016) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD, volumes en unités, prix en USD |
|
Segments couverts |
Par type de produit (dispositifs thérapeutiques, dispositifs de surveillance des patients, dispositifs de diagnostic, unités et systèmes de soins intensifs et autres dispositifs), population de patients (néonatale, pédiatrique, adulte et gériatrique), utilisateur final (hôpitaux, cliniques spécialisées, centres de chirurgie ambulatoire et autres), canal de distribution (appels d'offres directs, ventes au détail, distribution à des tiers et autres). |
|
Pays couverts |
États-Unis, Canada et Mexique. |
|
Acteurs du marché couverts |
Français Royal Philips NV, General Electric Company, COOK MEDICAL LLC, Abbott, Medtronic, Getinge AB, heyer medical AG, Drägerwerk AG & Co. KGaA, ICU Medical, Inc., NIHON KOHDEN CORPORATION., Fresenius Medical Care AG & Co. KGaA, Skanray Technologies Ltd., Boston Scientific Corporation, STERIS, Advin Health Care, Baxter, SS TECHNOMED (P) LTD., SCHILLER, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nonin, Dixion distribution of medical devices GmbH, Masimo et Compumedics Limited, entre autres. |
Définition du marché
Les équipements critiques sont indispensables aux soins prodigués aux patients dans des conditions de fonctionnement normales et leur défaillance pourrait entraîner des blessures graves imminentes ou la mort des patients ou des utilisateurs. Les soins critiques sont également appelés soins intensifs. Il s'agit d'un type de soins qui implique le traitement et la gestion des blessures et des maladies très graves qui peuvent mettre la vie en danger. Les complications chirurgicales, les blessures accidentelles, les infections graves et les problèmes respiratoires graves sont quelques exemples de conditions qui peuvent nécessiter des soins intensifs.
Les patients recevant ce niveau de soins peuvent se sentir mieux et passer à d'autres types de soins, mais de nombreuses personnes meurent en soins intensifs. L'équipement utilisé pour les soins intensifs est connu sous le nom d'équipement de soins intensifs, qui comprend des appareils de surveillance des patients, des unités et systèmes de soins intensifs et des appareils thérapeutiques, entre autres. L'unité de soins intensifs ou unité de soins intensifs (USI) est une unité hautement spécialisée et dédiée de l'hôpital pour les patients nécessitant une surveillance intensive des services médicaux, chirurgicaux et de soins aux patients. Les soins intensifs sont administrés dans une unité de soins intensifs, qui dans certains endroits est appelée unité de soins intensifs.
Dynamique du marché des équipements de soins intensifs en Amérique du Nord
Cette section traite de la compréhension des moteurs, des avantages, des opportunités, des contraintes et des défis du marché. Tout cela est discuté en détail ci-dessous :
Conducteurs
- Augmentation de la prévalence des maladies chroniques
Le changement des habitudes de vie, comme le tabagisme, la consommation d'alcool, le mode de vie sédentaire et bien d'autres, a augmenté le nombre de patients souffrant de maladies chroniques. La prévalence croissante des maladies chroniques stimule le marché et influence positivement le marché des équipements de soins intensifs.
- Augmentation de la population gériatrique
L’augmentation des maladies et l’augmentation rapide de la population gériatrique auront un impact considérable sur le marché des équipements de soins intensifs. En outre, la population gériatrique est vulnérable et souffre de peu de maladies irréversibles et chroniques. L’augmentation de la population gériatrique aura un impact positif sur le marché et agira comme un moteur de la croissance du marché des équipements de soins intensifs.
Retenue
- Manque de professionnels qualifiés
The lack of capable laboratory professionals is not a new story in diagnosis and healthcare. As with the increased burden of chronic diseases, the aging population and the development of healthcare insurance have increased the demand for healthcare laboratory professionals. Another reason is the lack of training sessions for the professionals.
Factors such as the retention rate, workload, and lack of certification are reasons for the lack of trained laboratory human resources, lack of education, and a relevant degree. These factors hamper the growth of the North America critical care equipment market.
- High cost of equipment
Equipment is needed for medical purposes in every department, such as surgery, orthopedics, chest medicines, and others. Mechanical equipment such as ventilators is required for external breathing support for the patients. Also, the major cost of the equipment depends upon its maintenance.
According to the Supervasi Foundation, one-day expenditure of the price of an ICU unit in India is around USD 67.17 per day, including highly-trained medical professionals. Moreover, ideally, the ICU department should comprise around 2 to 5 pieces of critical care equipment in each hospital, but due to the high cost of the equipment systems and high maintenance cost of the units in poor economic countries or rural areas hampers the growth
Opportunity
-
Growth in healthcare expenditure
Growing healthcare infrastructure helps provide better critical care, leading to faster recovery and rehabilitation into normal life. Also, as an investment in healthcare increases, more people are getting aware and desire advanced critical care equipment and diagnosing their health for precaution and cure.
Increasing healthcare expenditure for critical care treatment also helps patients to take hassle-free advanced treatment for better diagnosis and fast recovery. The spending on health is made up of self-pay or the combination of government expenditure by welfare schemes and sources, including health insurance and activities by non-governmental organizations, due to which faster recovery and rehabilitation into normal life is acting as an opportunity for growing the demand of the market.
An increase in healthcare expenditure leads to the implementation of advanced technologies equipment & products, and better treatment for critical care patients, leading to faster recovery. For this reason, faster recovery and rehabilitation into a normal life are expected to act as an opportunity for growing the demand for the North America critical care equipment market.
-
Rise in technical developments in equipments
Critical care has always been a technology- and data-dependent field. As big data and technology potentially revolutionize critical care practice, professional societies are well-positioned to partner with patients, families, practitioners, researchers, industry leaders, policymakers, and administrators to ensure that humanistic, high-value, ever-improving patient care remains the central goal for the future of critical care medicine.
Recent technological innovations are the predicted speculation about the future of critical care. The rising technical developments in critical care will continue to be multi-professional, with diverse generalists, therapists, specialists, and subspecialists seamlessly collaborating toward the common goal of optimal and humanistic patient care in a learning healthcare system. The wearable technology will optimize staffing patterns by tracking and mitigating excessive workloads while monitoring for mental and physical fatigue and distraction that could worsen patient care
Challenge
- Healthcare staff shortages
Maintaining appropriate staffing in healthcare facilities is essential for providing a safe work environment for patient care. When staffing shortages are anticipated, healthcare facilities and employers, in collaboration with human resources and occupational health services, use contingency capacity strategies to plan and prepare for mitigating the problems, such as adjusting staff schedules, hiring additional skilled staff, and rotating positions that support patient care activities.
The healthcare staff and nursing profession continue to face shortages due to a lack of potential educators, high turnover, and inequitable workforce distribution. The causes of the nursing shortage are numerous, and issues of concern are that some regions have a surplus of nurses and lower growth potential while others struggle to fulfill the local population's basic needs.
Post-COVID-19 Impact on North America Critical Care Equipment Market
Growth in the incidence of COVID-19 patients anticipated to propel the demand for medical devices such as ventilators, spirometers, oxygen concentrators, anesthesia machines, CPAP/BIPAP, and others. Moreover, advancement in technology acts as a driver for its growth in the market. However, the high cost of the devices and the risk associated with the use of ventilators act as a restraint to its growth in the market.
Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launches, and strategic partnerships to improve the technology and test results involved in the North America critical care equipment market.
Recent Developments
- En septembre 2021, SensaCore a annoncé le lancement de l'analyseur de gaz du sang ST-200 CC Ultra Smart, qui est le modèle de gaz du sang très avancé de Sensacore, et c'est un système électrolytique entièrement automatisé et contrôlé par microprocesseur qui utilise la mesure directe du courant avec l'électrode sélective d'ions (ISE), l'impédance (Hct) et la technologie d'ampérométrie (pO2) pour effectuer des analyses de gaz du sang artériel et des mesures d'électrolytes.
- En août 2021, Dixion Distribution of Medical Devices GMBH a annoncé avoir obtenu avec succès l'enregistrement auprès de la FDA. La première série d'équipements, à savoir les tables d'opération chirurgicales et les éclairages chirurgicaux Convelar, a reçu les certifications FDA en plus de la certification CE déjà existante.
Portée du marché nord-américain des équipements de soins intensifs
Le marché nord-américain des équipements de soins intensifs est segmenté en fonction du type de produit, de la population de patients, de l'utilisateur final et du canal de distribution. La croissance entre les segments vous aide à analyser les niches de croissance et les stratégies pour aborder le marché et déterminer vos principaux domaines d'application et la différence entre vos marchés cibles.
PAR TYPE DE PRODUIT
- Dispositifs thérapeutiques
- Dispositifs de surveillance des patients
- Appareils de diagnostic
- Unités et systèmes de soins intensifs
- Autres appareils
Sur la base du type de produit, le marché nord-américain des équipements de soins intensifs est segmenté en appareils thérapeutiques, appareils de surveillance des patients, appareils de diagnostic, systèmes et unités de soins intensifs et autres appareils.
PAR POPULATION DE PATIENTS
- Néonatal
- Pédiatrique
- Adultes
- Gériatrie
Sur la base de la population de patients, le marché nord-américain des équipements de soins intensifs est segmenté en néonataux, pédiatriques, adultes et gériatriques.
PAR UTILISATEUR FINAL
- Hôpitaux
- Cliniques spécialisées
- Centres de chirurgie ambulatoire
- Autres
Sur la base de l’utilisateur final, le marché nord-américain des équipements de soins intensifs est segmenté en hôpitaux, cliniques spécialisées, centres de chirurgie ambulatoire et autres.
PAR CANAL DE DISTRIBUTION
- Appel d'offres direct
- Ventes au détail
- Distribution à des tiers
- Autres
Sur la base du canal de distribution, le marché nord-américain des équipements de soins intensifs est segmenté en appels d'offres directs, ventes au détail, distribution à des tiers et autres.
Analyse/perspectives régionales du marché des équipements de soins intensifs en Amérique du Nord
Le marché des équipements de soins intensifs en Amérique du Nord est analysé et des informations sur la taille du marché sont fournies : type de produit, population de patients, utilisateur final et canal de distribution.
Les pays couverts dans ce rapport de marché sont les États-Unis, le Canada et le Mexique.
- En 2023, les États-Unis devraient dominer le marché nord-américain des équipements de soins intensifs en raison de la présence d'acteurs clés sur le plus grand marché de consommation avec un PIB élevé. Ce marché devrait croître en raison des nouvelles avancées technologiques sur le marché des équipements de soins intensifs.
La section par pays du rapport fournit également des facteurs individuels ayant un impact sur le marché et des changements dans la réglementation du marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie du pays, les actes réglementaires et les tarifs douaniers d'import-export sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario du marché pour les différents pays. En outre, la présence et la disponibilité des marques nord-américaines et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, ainsi que l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.
Analyse du paysage concurrentiel et des parts de marché des équipements de soins intensifs en Amérique du Nord
Le paysage concurrentiel du marché des équipements de soins intensifs en Amérique du Nord fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements en R&D, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les approbations de produits, les brevets, la largeur et l'étendue des produits, la domination des applications et la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise vers le marché des équipements de soins intensifs en Amérique du Nord.
Français Certains des principaux acteurs opérant sur le marché des équipements de soins intensifs en Amérique du Nord sont Koninklijke Philips NV, General Electric Company, COOK MEDICAL LLC, Abbott, Medtronic, Getinge AB, heyer medical AG, Drägerwerk AG & Co. KGaA, ICU Medical, Inc., NIHON KOHDEN CORPORATION., Fresenius Medical Care AG & Co. KGaA, Skanray Technologies Ltd., Boston Scientific Corporation, STERIS, Advin Health Care, Baxter, SS TECHNOMED (P) LTD., SCHILLER, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nonin, Dixion distribution of medical devices GmbH, Masimo et Compumedics Limited, entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 MULTIVARIATE MODELING
2.6 PRODUCT TYPE LIFELINE CURVE
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 INDUSTRY INSIGHTS
5.1 CONCLUSION:
6 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: REGULATORY SCENARIO
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISORDERS
7.1.2 INCREASED NUMBER OF PATIENTS TREATED IN EMERGENCY CARE AND INTENSIVE CARE UNITS
7.1.3 INCREASE IN THE NUMBER OF PRODUCT LAUNCHES AND ADVANCE IN TECHNOLOGY.
7.1.4 RISE IN THE GERIATRIC POPULATION
7.2 RESTRAINTS
7.2.1 LACK OF SKILLED PROFESSIONALS
7.2.2 STRINGENT REGULATION FOR PRODUCT APPROVAL
7.2.3 HIGH COST OF EQUIPMENT
7.3 OPPORTUNITIES
7.3.1 GROWTH IN HEALTHCARE EXPENDITURE
7.3.2 RISE IN TECHNICAL DEVELOPMENTS IN EQUIPMENTS
7.3.3 STRATEGIC INITIATIVES BY KEY PLAYERS
7.4 CHALLENGES
7.4.1 HEALTHCARE STAFF SHORTAGES
7.4.2 LACK OF TRAINING AND IMPROPER CARE BY STAFF
8 IMPACT OF COVID-19 ON THE NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET
8.1 AFTERMATH OF COVID-19 AND THE GOVERNMENT ROLE
8.2 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
8.3 PRICE IMPACT
8.4 IMPACT ON SUPPLY CHAIN
8.5 IMPACT ON DEMAND
8.6 CONCLUSION
9 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 THERAPEUTIC DEVICES
9.2.1 VENTILATOR
9.2.1.1 VENTILATOR, BY TYPE
9.2.1.1.1 INVASIVE
9.2.1.1.1.1 VOLUME-CYCLED VENTILATORS
9.2.1.1.1.2 PRESSURE-CYCLED VENTILATORS
9.2.1.1.1.3 CONTINUOUS POSITIVE AIRWAY PRESSURE VENTILATORS
9.2.1.1.1.4 BI-LEVEL POSITIVE AIRWAY PRESSURE VENTILATORS
9.2.1.1.1.5 FLOW-CYCLED VENTILATORS
9.2.1.1.1.6 TIME-CYCLED VENTILATORS
9.2.1.1.2 NON-INVASIVE
9.2.1.1.2.1 CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP)
9.2.1.1.2.2 AUTOTITRATING (ADJUSTABLE) POSITIVE AIRWAY PRESSURE (APAP)
9.2.1.1.2.3 BILEVEL POSITIVE AIRWAY PRESSURE (BIPAP)
9.2.1.2 VENTILATOR, BY PRODUCT
9.2.1.2.1 HIGH-END VENTILATORS
9.2.1.2.2 BASIC VENTILATORS
9.2.1.2.3 MID-END VENTILATORS
9.2.2 DEFIBRILLATOR & SUCTION PUMP
9.2.3 PHOTOTHERAPY EQUIPMENT
9.2.4 SYRINGE PUMPS
9.3 PATIENT MONITORING DEVICES
9.3.1 CARDIAC MONITORING DEVICES
9.3.1.1 EVENT MONITORS
9.3.1.2 ECG DEVICES
9.3.1.3 IMPLANTABLE LOOP RECORDERS
9.3.2 RESPIRATORY MONITORING DEVICES
9.3.2.1 PULSE OXIMETERS
9.3.2.2 SPIROMETERS
9.3.2.3 CAPNOGRAPHS
9.3.2.4 PEAK FLOW METERS
9.3.3 NEUROMONITORING DEVICES
9.3.3.1 ELECTROENCEPHALOGRAPH MACHINES
9.3.3.2 ELECTROMYOGRAPHY MACHINE
9.3.3.3 MAGNETOENCEPHALOGRAPH MACHINES
9.3.3.4 CEREBRAL OXIMETERS
9.3.3.5 INTRACRANIAL PRESSURE MONITORS
9.3.3.6 TRANSCRANIAL DOPPLER MACHINES
9.3.4 TEMPERATURE MONITORING DEVICES
9.3.4.1 HANDHELD TEMPERATURE MONITORING DEVICES
9.3.4.2 TABLE-TOP TEMPERATURE MONITORING DEVICES
9.3.4.3 INVASIVE TEMPERATURE MONITORING DEVICES
9.3.5 HEMODYNAMIC/PRESSURE MONITORING DEVICES
9.3.5.1 HEMODYNAMIC MONITORS
9.3.5.2 BLOOD PRESSURE MONITORING DEVICES
9.3.5.3 DISPOSABLES
9.3.6 MULTI-PARAMETER MONITORING DEVICES
9.3.6.1 HIGH-ACUITY MONITORING DEVICES
9.3.6.2 LOW-ACUITY MONITORING DEVICES
9.3.6.3 MID-ACUITY MONITORING DEVICES
9.4 DIAGNOSTIC DEVICES
9.4.1 ELECTROCARDIOGRAM (ECG) MACHINE
9.4.2 MOBILE X-RAY MACHINE
9.4.3 ULTRASONOGRAPHY MACHINE
9.4.4 ABG MACHINE
9.5 ICU UNITS & SYSTEMS
9.5.1 MEDICAL SUPPLY SYSTEMS
9.5.1.1 CEILING SUPPLY UNITS
9.5.1.2 WALL-MOUNT SUPPLY UNITS
9.5.2 SURGICAL AND EXAMINATION LIGHTS
9.5.2.1 SURGICAL LIGHT
9.5.2.2 EXAMINATION LIGHT
9.5.3 OTHERS
9.6 OTHER DEVICES
9.6.1 MEDICAL ACCESSORIES AND CONSUMABLES
9.6.1.1 CATHETERS
9.6.1.2 ECG LEADS
9.6.1.3 BABYFLOW PLUS
9.6.1.4 ANESTHESIA CIRCUIT KITS
9.6.1.5 POSITIVE AIRWAYS PRESSURE (PAP) SYSTEM
9.6.1.6 OTHERS
9.6.2 INFANT WARMERS & INCUBATORS
9.6.2.1 NICU WARMERS
9.6.2.2 TRANSPORT INCUBATOR
9.6.2.3 LABOR AND DELIVERY WARMER
9.6.3 INFUSION PUMP
9.6.4 ANESTHESIA MACHINE
9.6.5 BLOOD WARMER
9.6.6 SLEEP APNEA DEVICES
9.6.7 OTHERS
10 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION
10.1 OVERVIEW
10.2 NEONATAL
10.3 PEDIATRIC
10.4 GERIATRIC
10.5 ADULTS
11 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.2.1 ACUTE CARE HOSPITALS
11.2.2 LONG TERM CARE HOSPITALS
11.3 SPECIALTY CLINICS
11.4 AMBULATORY SURGICAL CENTRES
11.5 OTHERS
12 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 RETAIL SALES
12.3 DIRECT TENDER
12.4 THIRD PARTY DISTRIBUTION
12.5 OTHERS
13 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 KONINKLIJKE PHILIPS N.V.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 ABBOTT
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 GENERAL ELECTRIC COMPANY
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 BAXTER
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 MEDTRONIC
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 ADVIN HEALTH CARE
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 BOSTON SCIENTIFIC CORPORATION
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 COMPUMEDICS LIMITED
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPMENTS
16.9 COOK
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 DRÄGERWERK AG & CO. KGAA.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 DIXION DISTRIBUTION OF MEDICAL DEVICES GMBH
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 FRESENIUS SE & CO. KGAA
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENT
16.13 GETING AB
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 HEYER MEDICAL AG
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 ICU MEDICAL
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 MASIMO
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS.
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 NIHON KOHDEN CORPORATION
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 NONIN
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 STERIS
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 PRODUCT PORTFOLIO
16.19.4 RECENT DEVELOPMENTS
16.2 SKANRAY TECHNOLOGIES INC
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 SS TECHNOMED (P) LTD.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 SCHILLER
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
16.23 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Liste des tableaux
TABLE 1 RESPIRATORY DISEASES WORLDWIDE HEALTH BURDEN IN 2019
TABLE 2 PRICES OF A FEW VENTILATORS
TABLE 3 AVERAGE DAILY COST FOR STAY IN ICU BY HOSPITAL TYPE, 2013–2014
TABLE 4 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA NON-INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA NEONATAL IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA PEDIATRIC IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA GERIATRIC IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA ADULTS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA SPECIALTY CLINICS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA AMBULATORY SURGICAL CENTRES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA OTHERS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA RETAIL SALES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA DIRECT TENDER IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA THIRD PARTY DISTRIBUTION IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA OTHERS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 NORTH AMERICA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 49 NORTH AMERICA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 50 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 52 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 53 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA NON-INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 59 NORTH AMERICA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 60 NORTH AMERICA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 61 NORTH AMERICA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 62 NORTH AMERICA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 63 NORTH AMERICA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 NORTH AMERICA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 65 NORTH AMERICA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 66 NORTH AMERICA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 NORTH AMERICA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 68 NORTH AMERICA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 69 NORTH AMERICA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 70 NORTH AMERICA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 71 NORTH AMERICA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 72 NORTH AMERICA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 73 NORTH AMERICA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 74 NORTH AMERICA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 75 NORTH AMERICA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 NORTH AMERICA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 77 NORTH AMERICA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 78 NORTH AMERICA ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 NORTH AMERICA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 80 NORTH AMERICA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 81 NORTH AMERICA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 82 NORTH AMERICA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 NORTH AMERICA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 84 NORTH AMERICA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 85 NORTH AMERICA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 86 NORTH AMERICA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 87 NORTH AMERICA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 88 NORTH AMERICA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 89 NORTH AMERICA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 90 NORTH AMERICA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 91 NORTH AMERICA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 92 NORTH AMERICA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 93 NORTH AMERICA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 94 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 95 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 96 NORTH AMERICA HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY END USER 2021-2030 (USD MILLION)
TABLE 97 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 98 U.S. CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 U.S. THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 U.S. THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 101 U.S. THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 102 U.S. VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 103 U.S. VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 104 U.S. VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 105 U.S. VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 U.S. INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 107 U.S. NON-INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 108 U.S. PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 109 U.S. CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 110 U.S. CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 111 U.S. CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 112 U.S. RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 U.S. RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 114 U.S. RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 115 U.S. NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 U.S. NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 117 U.S. NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 118 U.S. TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 U.S. TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 120 U.S. TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 121 U.S. HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 U.S. HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 U.S. HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 124 U.S. HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 125 U.S. MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 126 U.S. MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 127 U.S. MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 128 U.S. DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 129 U.S. DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 130 U.S. DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 131 U.S. ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 U.S. MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 U.S. MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 134 U.S. MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 135 U.S. SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 U.S. SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 137 U.S. SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 138 U.S. OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 U.S. OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 140 U.S. OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 141 U.S. MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 U.S. MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 143 U.S. MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 144 U.S. INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 U.S. INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 146 U.S. INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 147 U.S. CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 148 U.S. CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 149 U.S. HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY END USER 2021-2030 (USD MILLION)
TABLE 150 U.S. CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 151 CANADA CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 152 CANADA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 CANADA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 154 CANADA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 155 U.S. VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 156 CANADA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 157 CANADA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 158 CANADA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 159 CANADA INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 CANADA NON-INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 CANADA PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 162 CANADA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 163 CANADA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 164 CANADA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 165 CANADA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 166 CANADA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 167 CANADA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 168 CANADA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 169 CANADA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 170 CANADA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 171 CANADA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 172 CANADA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 173 CANADA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 174 CANADA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 175 CANADA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 176 CANADA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 177 CANADA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 178 CANADA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 179 CANADA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 180 CANADA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 CANADA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 182 CANADA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 183 CANADA ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 CANADA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 185 CANADA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 186 CANADA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 187 CANADA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 188 CANADA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 189 CANADA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 190 CANADA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 191 CANADA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 192 CANADA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 193 CANADA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 194 CANADA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 195 CANADA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 196 CANADA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 CANADA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 198 CANADA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 199 CANADA CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 200 CANADA CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 201 CANADA HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY END USER 2021-2030 (USD MILLION)
TABLE 202 CANADA CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 203 MEXICO CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 MEXICO THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 205 MEXICO THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 206 MEXICO THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 207 MEXICO VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 208 MEXICO VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 209 MEXICO VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 210 MEXICO VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 211 MEXICO INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 MEXICO NON-INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 MEXICO PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 MEXICO CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 MEXICO CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 216 MEXICO CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 217 MEXICO RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 MEXICO RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 219 MEXICO RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 220 MEXICO NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 MEXICO NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 222 MEXICO NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 223 MEXICO TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 224 MEXICO TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 225 MEXICO TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 226 MEXICO HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 227 MEXICO HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 228 MEXICO HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 229 MEXICO MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 230 MEXICO MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 231 MEXICO MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 232 MEXICO DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 233 MEXICO DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 234 MEXICO DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 235 MEXICO ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 236 MEXICO MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 237 MEXICO MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 238 MEXICO MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 239 MEXICO SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 240 MEXICO SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 241 MEXICO SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 242 MEXICO OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 243 MEXICO OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 244 MEXICO OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 245 MEXICO MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 246 MEXICO MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 247 MEXICO MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 248 MEXICO INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 249 MEXICO INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 250 MEXICO INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 251 MEXICO CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 252 MEXICO CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 253 MEXICO HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY END USER 2021-2030 (USD MILLION)
TABLE 254 MEXICO CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
Liste des figures
FIGURE 1 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: NORTH AMERICA VS. REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: SEGMENTATION
FIGURE 12 INCREASING CHRONIC DISORDERS AND THE NUMBER OF PATIENT IN ICU AND NICU IS EXPECTED TO DRIVE THE NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 13 THERAPEUTIC DEVICES IS EXPECTED TO HAVE THE LARGEST SHARE OF NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET FROM 2023 TO 2030
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET
FIGURE 15 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PRODUCT TYPE, 2022
FIGURE 16 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 17 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 18 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PATIENT POPULATION, 2022
FIGURE 20 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PATIENT POPULATION, 2023-2030 (USD MILLION)
FIGURE 21 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PATIENT POPULATION, CAGR (2023-2030)
FIGURE 22 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PATIENT POPULATION, LIFELINE CURVE
FIGURE 23 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY END USER, 2022
FIGURE 24 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 25 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY END USER, CAGR (2023-2030)
FIGURE 26 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 27 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 28 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 29 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 30 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 31 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: SNAPSHOT (2022)
FIGURE 32 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY COUNTRY (2022)
FIGURE 33 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY COUNTRY (2023 & 2030)
FIGURE 34 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY COUNTRY (2022 & 2030)
FIGURE 35 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: PRODUCT TYPE (2023-2030)
FIGURE 36 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
